* Genomics-based Drug Design Solution
A coordinated suite of software, servers, and services to assist drug discovery researchers
 * ZOEGENE Corporation
A wholly owned subsidiary of Mitsubishi Chemical that develops and licenses tools for genomics-based drug development.
 * AXE, Inc.
Kyoto-based company that develops and markets embedded operating systems for PDAs and other mobile devices. Representative director: Shozo Takeoka.
 * GROMACS
A program for calculating molecular dynamics, developed at Groningen University, available under the GNU General Public License, which allows others to revise, redistribute, and sell variations of the software as long as any revisions to the source code are disclosed to the public.
Fujitsu is a leading provider of customer-focused IT and communications solutions for the global marketplace. Pace-setting technologies, highly reliable computing and telecommunications platforms, and a worldwide corps of systems and services experts uniquely position Fujitsu to deliver comprehensive solutions that open up infinite possibilities for its customers' success. Headquartered in Tokyo, Fujitsu Limited (TSE:6702) reported consolidated revenues of 4.6 trillion yen (US$38 billion) for the fiscal year ended March 31, 2003.
For more information, please see: www.fujitsu.com
Press ContactsPublic & Investor Relations
Phone: +81 (0) 3-6252-2176
Fax: +81 (0) 3-6252-2783
Technical ContactsBio-IT Laboratory
All company/product names mentioned may be trademarks or registered trademarks of their respective holders and are used for identification purpose only.
Please understand that product prices, specifications and other details are current on the day of issue of the press release, however, may change thereafter without notice.
Date: 05 November, 2003
Company: Fujitsu Limited, , , , ,
Share this page